Invitrocue establishes Hong Kong Laboratory

Invitrocue establishes Hong Kong Laboratory

Innovative life sciences company Invitrocue Limited (ASX: IVQ) (‘Invitrocue’ or ‘the Company’) is pleased to announce the establishment of laboratory facility in Hong Kong.

The Hong Kong facility, which will be used for research and development and for commercial purposes, provides Invitrocue with better access to the network of supportive early adopters of its unique Onco-PDO technology in the region. This includes primarily oncologist and hospital groups based in Hong Kong and also opportunities in mainland China and Macau.

invitrocue-establishes-hong-kong-laboratory